柚皮素抗乳腺癌作用机制的研究进展(4)
[15] Middleton E J，Kandaswami C，Theoharides T C.The effects of plant flavonoids on mammalian cells：implications for inflammation， heart disease，and cancer[J].Pharmacol Rev，2000，52(4)：673-751.
[16] Kris-Etherton P M，Hecker K D，Bonanome A，et al.Bioactive compounds in foods：their role in the prevention of cardiovascular disease and cancer[J].Am J Med，2002，113 Suppl 9B(9)：71S-88S.
[17] Harmon A W，Patel Y M.Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells： A Mechanism for Impaired Cellular Proliferation[J].Breast Cancer Research & Treatment 2004，85(2)：103-110.
[18] Nie Y C，Wu H，Li P B，et al.Naringin attenuates EGF-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-IκB-NF-κB signaling pathways[J].Eur J Pharmacol，2012，690(1-3)：207-213.
[19] Hatkevich T，Ramos J，Santos-Sanchez I，et al.A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells[J].Experimental Cell Research，2014，327(2)：331-339.
[20] Sandhu P S，Kumar R，Beg S，et al.Natural lipids enriched self-nano-emulsifying systems for effective co-delivery of tamoxifen and naringenin：Systematic approach for improved breast cancer therapeutics[J].Nanomedicine，2017，13(5)：1703-1713.
[21] Kitagawa S. Inhibitory effects of polyphenols on p-glycoprotein-mediated transport[J].Biol Pharm Bull，2006，29(1)：1-6.
[22] van Zanden J J，Wortelboer H M，Bijlsma S，et al.Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2[J].Biochem Pharmacol，2005，69(4)：699-708.
[23] Zhang F Y，Du G J，Zhang L，et al.Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein[J].Pharmaceutical Research，2009，26(4)：914-925.
(收稿日期：2017-12-05) (本文編辑：周亚杰), http://www.100md.com(李亚东 张远起 李建文)
[16] Kris-Etherton P M，Hecker K D，Bonanome A，et al.Bioactive compounds in foods：their role in the prevention of cardiovascular disease and cancer[J].Am J Med，2002，113 Suppl 9B(9)：71S-88S.
[17] Harmon A W，Patel Y M.Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells： A Mechanism for Impaired Cellular Proliferation[J].Breast Cancer Research & Treatment 2004，85(2)：103-110.
[18] Nie Y C，Wu H，Li P B，et al.Naringin attenuates EGF-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-IκB-NF-κB signaling pathways[J].Eur J Pharmacol，2012，690(1-3)：207-213.
[19] Hatkevich T，Ramos J，Santos-Sanchez I，et al.A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells[J].Experimental Cell Research，2014，327(2)：331-339.
[20] Sandhu P S，Kumar R，Beg S，et al.Natural lipids enriched self-nano-emulsifying systems for effective co-delivery of tamoxifen and naringenin：Systematic approach for improved breast cancer therapeutics[J].Nanomedicine，2017，13(5)：1703-1713.
[21] Kitagawa S. Inhibitory effects of polyphenols on p-glycoprotein-mediated transport[J].Biol Pharm Bull，2006，29(1)：1-6.
[22] van Zanden J J，Wortelboer H M，Bijlsma S，et al.Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2[J].Biochem Pharmacol，2005，69(4)：699-708.
[23] Zhang F Y，Du G J，Zhang L，et al.Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein[J].Pharmaceutical Research，2009，26(4)：914-925.
(收稿日期：2017-12-05) (本文編辑：周亚杰), http://www.100md.com(李亚东 张远起 李建文)
参见：首页 > 医疗版 > 疾病专题 > 普通外科 > 乳腺癌